The COPD Foundation was established to improve the lives of people with COPD, bronchiectasis, and nontuberculous mycobacterial (NTM) lung disease through initiatives that expand services and speed innovations which will make treatment more effective and affordable.
Find more information about GSK products and therapeutic areas impacted by the GSK portfolio of brands. Also, find links to educational resources for you and your patients.